溶解循环
铜绿假单胞菌
微生物学
噬菌体疗法
噬菌体
细菌
抗生素
病毒学
抗菌剂
抗生素耐药性
肌病毒科
抗药性
生物
溶原循环
细菌病毒
溶解
病毒
大肠杆菌
分子生物学
遗传学
基因
作者
Archana Maharjan,Roshan Nepal,Gunaraj Dhungana,Apshara Parajuli,Madhav Regmi,Elisha Upadhyaya,Dipendra Mandal,Mitesh Shrestha,Pragati Pradhan,Krishna Das Manandhar,Rajani Malla
标识
DOI:10.33314/jnhrc.v19i04.3837
摘要
Background: Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen frequently causing healthcare-associated infections. The apocalyptic rise of antimicrobial resistance has rekindled interest in age-old phage therapy that uses phages (viruses that infect bacteria) to kill the targeted pathogenic bacteria. Because of its specificity, phages are often considered as potential personalized therapeutic candidate for treating bacterial infections. Methods: In this study, we isolated and purified lytic phages against multi-drug resistant P. aeruginosa using soft agar overlay technique. Phage characteristics like thermal and pH stability, latent period and burst size were determined using one-step growth assay while multiple host range spectrum was determined by spot assay. The phages were further characterized using protein profiling. Results: Three Pseudomonas phages (øCDBT-PA31, øCDBT-PA56 and øCDBT-PA58) were isolated from the holy rivers of Kathmandu valley. Among 3 phages, øCDBT-PA31 demonstrated multiple host range and could lyse multi-drug resistant strain of P. aeruginosa. Further, øCDBT-PA31 showed latent period of 30 minutes with corresponding burst sizes of 423-525 PFU/cell. Interestingly, øCDBT-PA31 also tolerated a wide range of adverse conditions, such as high temperature (50°C) and pH 3-11. Further, protein profiling revealed that øCDBT-PA31 has 4 and øCDBT-PA11 had 3 distinct bands in the gradient gel ranging from approximately 3.5-29 kilodaltons (kDa) suggesting them to be morphologically distinct from each other. Conclusions: As multi-drug resistant bacteria are emerging as a global problem, lytic phages can be an alternative treatment strategy when all available antibiotics fail.Keywords: Antimicrobial resistance (AMR); bacteriophage; P. aeruginosa; phage therapy; SDS-PAGE.
科研通智能强力驱动
Strongly Powered by AbleSci AI